These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7459607)

  • 41. Association between capillaroscopy, haemorheological variables and plasma proteins in patients bearing Raynaud's phenomenon.
    Spengler MI; Svetaz MJ; Leroux MB; Leiva ML; Bottai HM
    Clin Hemorheol Microcirc; 2004; 30(1):17-24. PubMed ID: 14967879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemorrheological response to plasma exchange in Raynaud's syndrome.
    Dodds AJ; O'Reilly MJ; Yates CJ; Cotton LT; Flute PT; Dormandy JA
    Br Med J; 1979 Nov; 2(6199):1186-87. PubMed ID: 519354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Raynaud's syndrome: study of fingertip blood flow by plethysmography with venous occlusion (author's transl)].
    Cristol R; Graisely B; Cloarec M; Debray J
    Nouv Presse Med; 1979 Jan; 8(2):105-8. PubMed ID: 554069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Invariability of blood viscosity after cold testing in patients suffering for Raynaud's disease.
    Pola P; Savi L; Dal Lago A; Flore R; Shami J
    J Cardiovasc Surg (Torino); 1980; 21(2):211-4. PubMed ID: 7364865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of sympathetic blockade and cooling in Raynaud's phenomenon.
    Engelhart M
    Clin Physiol; 1990 Mar; 10(2):131-6. PubMed ID: 2318024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
    Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of digital artery adrenoceptors in Raynaud's disease.
    Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
    Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of biofeedback training in treatment of Raynaud's disease and phenomenon.
    Yocum DE; Hodes R; Sundstrom WR; Cleeland CS
    J Rheumatol; 1985 Feb; 12(1):90-3. PubMed ID: 3981523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular responses evoked by mild cool stimuli in primary Raynaud's disease: the role of endothelin.
    Edwards CM; Marshall JM; Pugh M
    Clin Sci (Lond); 1999 Jun; 96(6):577-88. PubMed ID: 10334963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of humeral blood flow during rewarming and recooling of the hand in normal subjects or presenting Raynaud's phenomenon].
    Savin E; Kedra AW; Oliva I; Bonnin P; Martineaud JP
    J Mal Vasc; 1989; 14(4):312-9. PubMed ID: 2685159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Sympatholytic effect of intra-arterial reserpine in sclerodermia and Raynaud's disease].
    Acevedo A; Palacios JM; López R; Palma F
    Rev Med Chil; 1984 Jun; 112(6):553-8. PubMed ID: 6515168
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon.
    Wise RA; Wigley F; Newball HH; Stevens MB
    Chest; 1982 Jun; 81(6):695-8. PubMed ID: 7075304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma levels of 5-hydroxytryptamine during sympathetic stimulation and in Raynaud's phenomenon.
    Coffman JD; Cohen RA
    Clin Sci (Lond); 1994 Mar; 86(3):269-73. PubMed ID: 8156737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of local temperature versus sympathetic tone on digital perfusion in Raynaud's phenomenon.
    Engelhart M; Seibold JR
    Angiology; 1990 Sep; 41(9 Pt 1):715-23. PubMed ID: 2221472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cold hypersenstivity in Raynaud's phenomenon.
    Jamieson GG; Ludbrook J; Wilson A
    Circulation; 1971 Aug; 44(2):254-64. PubMed ID: 4327362
    [No Abstract]   [Full Text] [Related]  

  • 57. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM; Malamet R; Wise RA
    J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The post-occlusive hyperemic response in patients with systemic sclerosis.
    Wigley FM; Wise RA; Mikdashi J; Schaefer S; Spence RJ
    Arthritis Rheum; 1990 Nov; 33(11):1620-5. PubMed ID: 2242060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon.
    Bunker CB; Reavley C; O'Shaughnessy DJ; Dowd PM
    Lancet; 1993 Jul; 342(8863):80-3. PubMed ID: 8100913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.